Related references
Note: Only part of the references are listed.Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer
Shiyuan Wang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden
Rong Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Response to Vemurafenib in Metastatic Triple-Negative Breast Cancer Harbouring a BRAF V600E Mutation: A Case Report and Electronically Captured Patient-Reported Outcome
Magdalena Pircher et al.
CASE REPORTS IN ONCOLOGY (2021)
Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer
Kyung Chan Park et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
THE BCL-2 FAMILY SAGA
Ana J. Garcia-Saez
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
Keith A. Lawson et al.
NATURE (2020)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Fibroblasts Fuel Immune Escape in the Tumor Microenvironment
Emiel A. De Jaeghere et al.
TRENDS IN CANCER (2019)
GSCALite: a web server for gene set cancer analysis
Chun-Jie Liu et al.
BIOINFORMATICS (2018)
Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation
Junmei Cairns et al.
EMBO REPORTS (2018)
DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4
Xin Jin et al.
MOLECULAR CELL (2018)
BRD4 and Cancer: going beyond transcriptional regulation
Benedetta Donati et al.
MOLECULAR CANCER (2018)
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
Masayuki Hiraki et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Methods, Tools and Current Perspectives in Proteogenomics
Kelly V. Ruggles et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Biomarkers of cancer cachexia
Audrey Loumaye et al.
CLINICAL BIOCHEMISTRY (2017)
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects
Hongyan Jia et al.
DRUG RESISTANCE UPDATES (2017)
PI3K signaling in cancer: beyond AKT
Evan C. Lien et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Treating cancer with selective CDK4/6 inhibitors
Ben O'Leary et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Personalized medicine in gastric cancer: Where are we and where are we going?
Alexandre A. Jacome et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
David M. Hyman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ImmPort: disseminating data to the public for the future of immunology
Sanchita Bhattacharya et al.
IMMUNOLOGIC RESEARCH (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
BCL2A1: the underdog in the BCL2 family
M. Vogler
CELL DEATH AND DIFFERENTIATION (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer
Josep Castellvi et al.
CANCER (2006)
Eradication of established tumors in mice by a combination antibody-based therapy
Tomoyasu Uno et al.
NATURE MEDICINE (2006)
Share Paper
